🎉 M&A multiples are live!
Check it out!

Pague Menos Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pague Menos and similar public comparables like D1000 Varejo Farma, Profarma Distribuidora, and SC Ropharma.

Pague Menos Overview

About Pague Menos

Empreendimentos Pague Menos SA operates a pharmacy chain in Brazil. It engaged in the retail trade of medicines, perfumes, personal hygiene, and beauty products. It revenues arises mainly from the sale of medicines, perfumes, and several self-service products to the end consumer.


Founded

1981

HQ

Brazil
Employees

n/a

Sectors

Pharmacies

Financials

LTM Revenue $2.8B

LTM EBITDA $155M

EV

$1.5B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Pague Menos Financials

As of November 2025, Pague Menos reported last 12-month revenue of $2.8B and EBITDA of $155M.

In the same period, Pague Menos generated $1.2B in LTM gross profit and $33.6M in net income.

See Pague Menos valuation multiples based on analyst estimates

Pague Menos P&L

In the most recent fiscal year, Pague Menos reported revenue of $2.4B and EBITDA of $180M.

Pague Menos expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Pague Menos valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $2.8B XXX $2.4B XXX XXX XXX
Gross Profit $1.2B XXX $755M XXX XXX XXX
Gross Margin 42% XXX 32% XXX XXX XXX
EBITDA $155M XXX $180M XXX XXX XXX
EBITDA Margin 6% XXX 8% XXX XXX XXX
EBIT $108M XXX $107M XXX XXX XXX
EBIT Margin 4% XXX 4% XXX XXX XXX
Net Profit $33.6M XXX $19.3M XXX XXX XXX
Net Margin 1% XXX 1% XXX XXX XXX
Net Debt XXX XXX $238M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Pague Menos Stock Performance

Pague Menos has current market cap of BRL 4.3B (or $808M), and EV of BRL 7.9B (or $1.5B).

Market Cap Evolution

Pague Menos Stock Data

As of December 4, 2025, Pague Menos's stock price is BRL 6 (or $1).

See Pague Menos trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.5B $808M XXX XXX XXX XXX $0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Pague Menos Valuation Multiples

Pague Menos's trades at 0.6x EV/Revenue multiple, and 8.3x EV/EBITDA.

See valuation multiples for Pague Menos and 15K+ public comps

Pague Menos Financial Valuation Multiples

As of December 4, 2025, Pague Menos has market cap of $808M and EV of $1.5B.

Equity research analysts estimate Pague Menos's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Pague Menos has a P/E ratio of 24.1x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $808M XXX $808M XXX XXX XXX
EV (current) $1.5B XXX $1.5B XXX XXX XXX
EV/Revenue 0.5x XXX 0.6x XXX XXX XXX
EV/EBITDA 9.6x XXX 8.3x XXX XXX XXX
EV/EBIT 13.7x XXX 13.9x XXX XXX XXX
EV/Gross Profit 1.3x XXX n/a XXX XXX XXX
P/E 24.1x XXX 41.8x XXX XXX XXX
EV/FCF -467.6x XXX 28.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Pague Menos Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Pague Menos Margins & Growth Rates

Pague Menos's last 12 month revenue growth is 12%

Pague Menos's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Pague Menos's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pague Menos's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Pague Menos and other 15K+ public comps

Pague Menos Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 12% XXX 15% XXX XXX XXX
EBITDA Margin 6% XXX 8% XXX XXX XXX
EBITDA Growth 19% XXX 2% XXX XXX XXX
Rule of 40 20% XXX 20% XXX XXX XXX
Bessemer Rule of X XXX XXX 37% XXX XXX XXX
Revenue per Employee XXX XXX n/a XXX XXX XXX
Opex per Employee XXX XXX n/a XXX XXX XXX
S&M Expenses to Revenue XXX XXX 24% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 27% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Pague Menos Public Comps

See public comps and valuation multiples for Pharmacies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Sigma Healthcare XXX XXX XXX XXX XXX XXX
MedPlus India XXX XXX XXX XXX XXX XXX
SC Ropharma XXX XXX XXX XXX XXX XXX
D1000 Varejo Farma XXX XXX XXX XXX XXX XXX
Profarma Distribuidora XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Pague Menos M&A and Investment Activity

Pague Menos acquired  XXX companies to date.

Last acquisition by Pague Menos was  XXXXXXXX, XXXXX XXXXX XXXXXX . Pague Menos acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Pague Menos

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Pague Menos

When was Pague Menos founded? Pague Menos was founded in 1981.
Where is Pague Menos headquartered? Pague Menos is headquartered in Brazil.
Is Pague Menos publicy listed? Yes, Pague Menos is a public company listed on BVMF.
What is the stock symbol of Pague Menos? Pague Menos trades under PGMN3 ticker.
When did Pague Menos go public? Pague Menos went public in 2020.
Who are competitors of Pague Menos? Similar companies to Pague Menos include e.g. Sigma Healthcare, MedPlus India, SC Ropharma, D1000 Varejo Farma.
What is the current market cap of Pague Menos? Pague Menos's current market cap is $808M
What is the current revenue of Pague Menos? Pague Menos's last 12 months revenue is $2.8B.
What is the current revenue growth of Pague Menos? Pague Menos revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Pague Menos? Current revenue multiple of Pague Menos is 0.5x.
Is Pague Menos profitable? Yes, Pague Menos is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Pague Menos? Pague Menos's last 12 months EBITDA is $155M.
What is Pague Menos's EBITDA margin? Pague Menos's last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of Pague Menos? Current EBITDA multiple of Pague Menos is 9.6x.
What is the current FCF of Pague Menos? Pague Menos's last 12 months FCF is -$3.2M.
What is Pague Menos's FCF margin? Pague Menos's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of Pague Menos? Current FCF multiple of Pague Menos is -467.6x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.